サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：インターベンショナル神経放射線学の世界市場-2023-2030年
市場調査レポート
商品コード
1345457

インターベンショナル神経放射線学の世界市場-2023-2030年

Global Interventional Neuroradiology Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 186 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
インターベンショナル神経放射線学の世界市場-2023-2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界のインターベンショナル神経放射線学市場は、2022年に19億米ドルに達し、2023～2030年の予測期間中にCAGR 5.8％で成長し、2030年には29億米ドルに達すると予測されています。

インターベンショナル神経放射線学治療は、鼠径部に挿入されたマイクロカテーテルをX線ガイド下に脳につながる血管に通すことで行われます。インターベンショナル神経放射線学の医師は現在、閉塞部位に直接血栓溶解薬を投与する脳卒中治療、動脈瘤の膨らみにプラチナコイルを挿入して血栓や破裂を防ぐ動脈瘤治療、骨折した椎骨にセメントを注入して骨を補強する脊椎治療など、さまざまな治療を低侵襲で行っています。

インターベンショナル神経放射線学の技術により、外科手術では到達が困難な脳や脊椎の領域にアクセスできることが多いです。この手技は低侵襲であるため、通常、入院期間や回復期間は短くなります。多くの場合、合併症や感染症のリスクも低いです。

さらに、世界のインターベンショナル神経放射線学市場は、高齢化の進行、低侵襲手技に対する需要の増加、脳動脈瘤の有病率の上昇など様々な要因によって牽引されています。しかし、塞栓用コイルのコストが高いこと、熟練した専門家が少ないことが市場成長を妨げる主な要因となっています。

ダイナミクス

脳動脈瘤の有病率の上昇

脳動脈瘤の有病率の増加は、予測期間中に市場が成長するための重要な要因の1つです。例えば、NCBIに掲載された脳動脈瘤に関する論文によると、脳動脈瘤の世界の有病率は約3.2％で、平均年齢は50歳、男女比は全体で1：1です。この比率は50歳を過ぎると大きく変化し、女性優位の比率が2：1に近づくが、これは循環エストロゲンの減少により血管組織のコラーゲン含量が減少するためと考えられています。SAHを引き起こす破裂の割合は10万人に約10人です。

これはフィンランド人や日本人など特定の集団ではより高いです。しかし、これはこれらの集団で動脈瘤の有病率が高いためではありません。動脈瘤性SAHによる全死亡率は全死因死亡の0.4～0.6％と考えられており、破裂が判明している患者では約20％の死亡率とさらに30～40％の罹患率があります。

技術の進歩

破壊的な技術は今後も開発され続け、インターベンショナル神経放射線学治療の方法を進化させるであろう。治療効果を向上させ、治療期間を短縮し、コストを削減し、患者中心のより良い転帰を可能にする変化が強く望まれています。

その技術のひとつが、インターベンショナル神経放射線学と生物医学ロボット工学が交差する新興分野であるロボット支援インターベンショナル神経放射線学です。血管内ロボットは、手技を自動化して手技時間を短縮し、安全性を高め、電離放射線に関連する労働災害を軽減し、神経インターベンションへの地理的アクセスのギャップを減らすためにケアのネットワークを拡大することができます。

ユニバーシティ・ヘルス・ネットワークのトロント・ウエスタン病院は、遠隔操作システムを用いて、人間初のロボット支援神経インターベンション手技を実施しました。Vitor Mendes Pereira医師が主導するこの画期的な手技は、脳卒中治療へのアクセスを改善し、動脈瘤破裂のリスクを低減することを目的としています。

このロボットシステムは、この種の神経インターベンション手術が可能な世界で唯一のものです。この処置では、ペレイラ医師がデジタル制御でロボットアームを操作し、ミリ単位の精度でマイクロカテーテルを脳血管に導き、コイルを展開して動脈瘤への血流を制限します。

放射線科医の不足

放射線科医の不足は、予測期間中の市場成長を妨げる主な要因の一つです。市場成長の低下は、ヘルスケア施設がインターベンショナル神経放射線学で使用される高価な機器への投資をためらう結果となります。

放射線科医の不足は、患者の転帰に遠大な影響を及ぼします。「タイムリーで正確な診断は、特に重篤な疾患において、適切な治療方針を決定する上で極めて重要な役割を果たします。診断の遅れや不正確さは、患者の安全性の低下、入院期間の長期化、ヘルスケアコストの増加につながります。さらに、限られた放射線技師にかかる膨大な負担は、燃え尽き症候群や疲労につながり、報告全体の質を低下させる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 脳動脈瘤の有病率の上昇
      • 技術の進歩
    • 抑制要因
      • 放射線科医の不足
    • 機会
      • 新興市場における製品上市の増加
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 デバイスタイプ別

  • マイクロカテーテル
  • 神経血管塞栓・コイリングアシストデバイス
  • 塞栓用コイル
  • 血流転換デバイス
  • 液体塞栓剤
  • アクセサリー
  • マイクロガイドワイヤー

第8章 用途別

  • 脳動脈瘤
  • 頭蓋内動脈硬化性腫瘍
  • 急性虚血性脳卒中
  • その他

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 診断センター

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Balt Extrusion
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Merit Medical Systems
  • Terumo Corporation
  • Medtronic
  • Penumbra, Inc.
  • Mediterra
  • Stryker
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • MicroVention Inc

第13章 付録

目次
Product Code: MD6815

Overview

Global Interventional Neuroradiology Market reached US$ 1.9 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 5.8% during the forecast period 2023-2030.

Interventional neuroradiology therapies are accomplished through microcatheters inserted in the groin area and, under X-ray guidance, threaded through the blood vessels leading into the brain. Interventional neuroradiologists currently employ minimally invasive procedures to accomplish a wide variety of treatments including stroke treatment by delivering clot-busting drugs directly to the site of the blockage; aneurysm therapy by inserting platinum coils into the aneurysm bulge to prevent clotting and rupture; and spinal treatments by injecting cement into a fractured vertebra to reinforce the bone.

Interventional neuroradiology techniques often allow us access to areas of the brain and spine that are surgically difficult to reach. Because the procedures are minimally invasive, hospital stays and recovery periods are normally shorter. In many cases, they also pose a lower risk for complications and infection

Furthermore, the global interventional neuroradiology market is driven by various factors like a progressively ageing population, increasing demand for minimally invasive procedures and a rise in the prevalence of the cerebral aneurysms. However, the high cost of embolization coils and the dearth of skilled professionals are the major factors hindering the market growth.

Dynamics

Rise in the Prevalence of Cerebral Aneurysms

The rise in the prevalence of cerebral aneurysms is one of the key factors that helps the market to grow during the forecast period. For instance, according to an article published on cerebral aneurysms in NCBI, the worldwide prevalence of cerebral aneurysms is approximately 3.2%, with a mean age of 50 and an overall 1:1 gender ratio. This ratio changes significantly after age 50, with an increasing female predominance approaching 2:1, thought to be due to decreased circulating estrogen causing a reduction in the collagen content of the vascular tissue. The rate of rupture causing SAH is about 10 per 100,000.

This is higher in certain populations such as the Finnish and Japanese. However, this is not due to a higher prevalence of aneurysms in these populations. The overall mortality due to aneurysmal SAH is considered to be 0.4 to 0.6% of all-cause deaths, with an approximate 20% mortality and an additional 30 to 40% morbidity in patients with known rupture.

Rise in the Technological Advancements

Disruptive technologies will continue to be developed and evolve the way interventional neuroradiology work is performed. Changes that improve treatment efficacy, shorten the duration of care, reduce costs and allow better patient-centred outcomes are highly desirable.

One of the technologies is Robotic-assisted interventional neuroradiology which is an emerging field at the intersection of interventional neuroradiology and biomedical robotics. Endovascular robotics can automate manoeuvres to reduce procedure times and increase safety, reduce occupational hazards associated with ionizing radiations, and expand networks of care to reduce gaps in geographic access to neuro interventions.

The University Health Network's Toronto Western Hospital has performed the first-in-human robot-assisted neuro-interventional procedure using a remote operation system. This groundbreaking procedure, led by Dr. Vitor Mendes Pereira, aims to improve stroke treatment access and reduce the risk of aneurysm rupture.

The robotic system is the only one in the world capable of this type of neuro-interventional procedure. The procedure involved Dr Pereira leading the robotic arm through digital controls, guiding a microcatheter with millimetric precision through brain vessels and deploying a coil, limiting blood flow to the aneurysm.

Shortage of Radiologists

A shortage of Radiologists is one of the key factors that hamper the market growth during the forecast period. The decline in market growth will result in healthcare facilities hesitating to invest in expensive devices that are used in interventional neuroradiology.

The shortage of radiologists has far-reaching consequences for patient outcomes. "Timely and accurate diagnoses play a pivotal role in determining the appropriate course of treatment, especially in critical conditions. Delayed or inaccurate diagnoses may lead to compromised patient safety, prolonged hospital stays, and increased healthcare costs. Furthermore, the immense burden on our limited radiology workforce can lead to burnout and fatigue, potentially compromising the overall quality of reporting.

Segment Analysis

The global interventional neuroradiology market is segmented based on device type, application, end-user and region.

The Microcatheters Segment From the Device Type Segment Accounted For Approximately 41.7% of Interventional Neuroradiology Share

The microcatheters segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. Microcatheters are small in size which helps to reduce the risk of vessel injury during the catheterization which helps the procedure to be processed safely during the timeline.

Microcatheters are soft and floppy as they are designed to be the least traumatic. Once a stable position is achieved with a guide catheter or distal access catheter, microcatheters are then advanced to the exact site in the cerebral vasculature. They have different lengths, diameters, stiffness, tractability, and radio-opaque markers, and some of them are even detachable for use in vascular malformations.

For instance, in March 2022 Guerbet announced it will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions becoming available.

The company obtained its original offering of 18 references of SeQure and DraKon microcatheters as part of its acquisition of Accurate Medical Therapeutics in 2018. It received the CE mark in April 2019 and was US Food and Drug Administration (FDA) in 2018. Guerbet now expands the portfolio, adding 20 versions for a total of 38, and launching a new line of Axessio guidewires with two diameters.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors like new device launches by key players, strategic partnerships within the companies, Heavy utilization of medical imaging technologies, advanced healthcare infrastructure, regulatory framework, patient awareness, market competitiveness will drive the region to be largest during the forecast period.

For instance, in February 2023 RAYUS Radiology, a leading national provider of advanced diagnostic and interventional medical imaging services, announced the renewal of its partnerships with US Ski & Snowboard, US Speedskating and USA Bobsled/Skeleton and will continue to serve as an official Medical Provider for all three organizations and the elite athletes they represent.

Competitive Landscape

The major global players in the market include: Balt Extrusion, Merit Medical Systems, Terumo Corporation, Medtronic, Penumbra, Inc., Mediterra, Stryker, Boston Scientific Corporation, Micro Port Scientific Corporation, MicroVention Inc. and others.

COVID-19 Impact Analysis

The COVID-19 pandemic has disrupted healthcare on an unprecedented scale. Covid had a minimal impact on the global neuroradiology market where neuro interventions were among the least affected, as most of these procedures fall under emergencies such as stroke, SAH, and intracerebral haemorrhage. neurointerventional procedures such as stroke thrombectomy and endovascular therapy for ruptured aneurysms increased marginally.

Moreover, Difficulties in providing essential/post-sales assistance due to lockdowns have degraded interventional neuroradiology products to end-users. Thus, the pandemic is not expected to have long-term effects on the primary growth drivers or end-users in the interventional neuroradiology market.

By Device Type

  • Microcatheters
  • Neurovascular Embolization & Coiling Assist Devices
  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Accessories
  • Micro guidewires

By Disease

  • Cerebral Aneurysms
  • Intra-cranial Atherosclerotic Tumors
  • Acute Ischemic Strokes
  • Other Diseases

End- User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In June 2023 Adept Medical announced the launch of the Head Immobilizer-a radiolucent support for a range of interventional radiology (IR) and neuroradiology procedures. Now commercially available, the positioning device can help mitigate the costs of retakes, from reducing the amount of mid-procedure interventions caused by head movement in awake patients, to enabling interventionists to consider conscious sedation as an option, as well as minimizing patient exposure to radiation.
  • In October 2022 RANZCR formally launched the Standards of Practice for Interventional Radiology and Interventional Neuroradiology at the 72nd Annual Scientific Meeting (ASM) in Adelaide. Applicable to all interventional radiology (IR) and interventional neuroradiology (INR) practices across Australia and New Zealand, these are the first comprehensive standards for the safe and effective preparation, delivery and follow-up of IR and INR services.
  • In June 2022, Sheikh Shakhbout Medical City (SSMC), one of the UAE's largest hospitals and a joint-venture partnership between Abu Dhabi Health Services Company (SEHA) and Mayo Clinic, established a new state-of-the-art, Biplane Angio Suite for the diagnosis and treatment of ischemic strokes. The brand-new service is under the Division of Interventional Neuroradiology which is part of the Clinical Imaging department.

Why Purchase the Report?

  • To visualize the global interventional neuroradiology market segmentation based on device type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global interventional neuroradiology market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global interventional neuroradiology market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Cerebral Aneurysms
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Shortage of Radiologists
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in the Product Launches in Emerging Markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Microcatheters*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Neurovascular Embolization & Coiling Assist Devices
  • 7.4. Embolic Coils
  • 7.5. Flow Diversion Devices
  • 7.6. Liquid Embolic Agents
  • 7.7. Accessories
  • 7.8. Microguidewires

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cerebral Aneurysms *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Intra-cranial Atherosclerotic Tumors
  • 8.4. Acute Ischemic Strokes
  • 8.5. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Diagnostic Centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Balt Extrusion *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Merit Medical Systems
  • 12.3. Terumo Corporation
  • 12.4. Medtronic
  • 12.5. Penumbra, Inc.
  • 12.6. Mediterra
  • 12.7. Stryker
  • 12.8. Boston Scientific Corporation
  • 12.9. MicroPort Scientific Corporation
  • 12.10. MicroVention Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us